Together Pharma (TGTR) Stock Overview
Through its subsidiaries, engages in the cultivation, propagation, import, export, production, storage and distribution of medical cannabis products in Israel. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 5/6 |
| Dividends | 0/6 |
TGTR Community Fair Values
Create NarrativeSee what others think this stock is worth. Follow their fair value or set your own to get alerts.
Together Pharma Ltd Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₪3.43 |
| 52 Week High | ₪5.42 |
| 52 Week Low | ₪3.04 |
| Beta | 0.27 |
| 1 Month Change | 2.97% |
| 3 Month Change | 7.97% |
| 1 Year Change | -14.85% |
| 3 Year Change | 13.89% |
| 5 Year Change | -83.21% |
| Change since IPO | -98.60% |
Recent News & Updates
Fewer Investors Than Expected Jumping On Together Pharma Ltd (TLV:TGTR)
Dec 21
Returns On Capital Signal Difficult Times Ahead For Together Pharma (TLV:TGTR)
Oct 30Recent updates
Fewer Investors Than Expected Jumping On Together Pharma Ltd (TLV:TGTR)
Dec 21Returns On Capital Signal Difficult Times Ahead For Together Pharma (TLV:TGTR)
Oct 30Why The 29% Return On Capital At Together Pharma (TLV:TGTR) Should Have Your Attention
Jan 07Market Cool On Together Pharma Ltd's (TLV:TGTR) Revenues
Nov 04Is Together Pharma (TLV:TGTR) A Risky Investment?
Sep 13Investors Holding Back On Together Pharma Ltd (TLV:TGTR)
Aug 02Together Pharma (TLV:TGTR) Is Achieving High Returns On Its Capital
May 31Further Upside For Together Pharma Ltd (TLV:TGTR) Shares Could Introduce Price Risks After 49% Bounce
Apr 04A Piece Of The Puzzle Missing From Together Pharma Ltd's (TLV:TGTR) Share Price
Dec 28Returns At Together Pharma (TLV:TGTR) Are On The Way Up
Nov 13Together Pharma (TLV:TGTR) Has A Somewhat Strained Balance Sheet
Oct 09Together Pharma Ltd's (TLV:TGTR) 35% Jump Shows Its Popularity With Investors
Sep 03Together Pharma Ltd's (TLV:TGTR) 35% Jump Shows Its Popularity With Investors
Sep 03Is Together Pharma (TLV:TGTR) Using Debt Sensibly?
May 27Is Together Pharma (TLV:TGTR) Using Too Much Debt?
Jan 05Together Pharma (TLV:TGTR) Is Looking To Continue Growing Its Returns On Capital
Oct 28Is Together Pharma (TLV:TGTR) Using Too Much Debt?
Sep 03Together Pharma (TLV:TGTR) Might Have The Makings Of A Multi-Bagger
Jul 29Here's Why Together Pharma (TLV:TGTR) Has A Meaningful Debt Burden
Apr 08Can Together Pharma (TLV:TGTR) Continue To Grow Its Returns On Capital?
Dec 24Shareholder Returns
| TGTR | IL Interactive Media and Services | IL Market | |
|---|---|---|---|
| 7D | -2.0% | -0.6% | -0.9% |
| 1Y | -14.9% | 43.5% | 52.0% |
Return vs Industry: TGTR underperformed the IL Interactive Media and Services industry which returned 46.9% over the past year.
Return vs Market: TGTR underperformed the IL Market which returned 50.4% over the past year.
Price Volatility
| TGTR volatility | |
|---|---|
| TGTR Average Weekly Movement | 5.2% |
| Interactive Media and Services Industry Average Movement | 5.2% |
| Market Average Movement | 4.7% |
| 10% most volatile stocks in IL Market | 7.8% |
| 10% least volatile stocks in IL Market | 3.2% |
Stable Share Price: TGTR has not had significant price volatility in the past 3 months compared to the IL market.
Volatility Over Time: TGTR's weekly volatility (5%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1991 | 199 | Nissim Bracha | www.together-pharma.com |
Together Pharma Ltd, through its subsidiaries, engages in the cultivation, propagation, import, export, production, storage and distribution of medical cannabis products in Israel. It offers oils and inflorescences. The company was incorporated in 1991 and is based in Ashkelon, Israel.
Together Pharma Ltd Fundamentals Summary
| TGTR fundamental statistics | |
|---|---|
| Market cap | ₪59.47m |
| Earnings (TTM) | -₪6.56m |
| Revenue (TTM) | ₪109.22m |
Is TGTR overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| TGTR income statement (TTM) | |
|---|---|
| Revenue | ₪109.22m |
| Cost of Revenue | ₪92.10m |
| Gross Profit | ₪17.12m |
| Other Expenses | ₪23.68m |
| Earnings | -₪6.56m |
Last Reported Earnings
Jun 30, 2025
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.38 |
| Gross Margin | 15.67% |
| Net Profit Margin | -6.01% |
| Debt/Equity Ratio | 76.4% |
How did TGTR perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2026/02/02 07:20 |
| End of Day Share Price | 2026/02/02 00:00 |
| Earnings | 2025/06/30 |
| Annual Earnings | 2024/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Together Pharma Ltd is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.